These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 29950528

  • 1. CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL).
    Ranuhardy D, Suzanna E, Sari RM, Hadisantoso DW, Andalucia R, Abdillah A.
    Acta Med Indones; 2018 Apr; 50(2):104-109. PubMed ID: 29950528
    [Abstract] [Full Text] [Related]

  • 2. CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine-needle aspiration cytology samples.
    Cozzolino I, Vitagliano G, Caputo A, Montella M, Franco R, Ciancia G, Selleri C, Zeppa P.
    Diagn Cytopathol; 2020 Mar; 48(3):211-216. PubMed ID: 31825183
    [Abstract] [Full Text] [Related]

  • 3. The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
    Gravanis I, Tzogani K, van Hennik P, de Graeff P, Schmitt P, Mueller-Berghaus J, Salmonson T, Gisselbrecht C, Laane E, Bergmann L, Pignatti F.
    Oncologist; 2016 Jan; 21(1):102-9. PubMed ID: 26621039
    [Abstract] [Full Text] [Related]

  • 4. The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas.
    Macalalad AR, McAuliffe M, Yang H, Kageleiry A, Zhong Y, Wu EQ, Shonukan O, Bonthapally V.
    Curr Med Res Opin; 2015 Mar; 31(3):537-45. PubMed ID: 25598441
    [Abstract] [Full Text] [Related]

  • 5. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
    Gharbaran R, Goy A, Tanaka T, Park J, Kim C, Hasan N, Vemulapalli S, Sarojini S, Tuluc M, Nalley K, Bhattacharyya P, Pecora A, Suh KS.
    J Hematol Oncol; 2013 Aug 29; 6():62. PubMed ID: 23988031
    [Abstract] [Full Text] [Related]

  • 6. Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients.
    Gandolfi L, Pellegrini C, Casadei B, Stefoni V, Broccoli A, Tonialini L, Morigi A, Argnani L, Zinzani PL.
    Oncologist; 2016 Dec 29; 21(12):1436-1441. PubMed ID: 27486201
    [Abstract] [Full Text] [Related]

  • 7. Hodgkin lymphoma with unusual intrasinusoidal pattern of infiltration.
    Lee SS, Ryoo BY, Park YH, Park S, Kim MS, Park KH, Kim CW.
    Leuk Lymphoma; 2004 Oct 29; 45(10):2135-41. PubMed ID: 15370261
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A, Gloghini A, Volpe R.
    Cancer; 1992 Dec 01; 70(11):2691-8. PubMed ID: 1330287
    [Abstract] [Full Text] [Related]

  • 9. IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.
    McQuaid DC, Katz SG, Xu ML.
    Am J Clin Pathol; 2022 Aug 04; 158(2):173-176. PubMed ID: 35460405
    [Abstract] [Full Text] [Related]

  • 10. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
    Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES.
    Am J Surg Pathol; 2012 May 04; 36(5):716-25. PubMed ID: 22367293
    [Abstract] [Full Text] [Related]

  • 11. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
    Cho RJ, McCalmont TH, Ai WZ, Fox LP, Treseler P, Pincus LB.
    J Cutan Pathol; 2012 Jun 04; 39(6):651-8. PubMed ID: 22324490
    [Abstract] [Full Text] [Related]

  • 12. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W, Tsang P, Liu Z, Wu CD, Dong HY, Goldstein M, Cohen P, Gangi M, Weisberger J.
    Int J Oncol; 2003 Feb 04; 22(2):319-24. PubMed ID: 12527929
    [Abstract] [Full Text] [Related]

  • 13. IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma.
    Tang H, Wei Q, Ge J, Jian W, Liu J, Zhong L, Fu B, Zhao T.
    Hum Pathol; 2013 Oct 04; 44(10):2167-72. PubMed ID: 23845468
    [Abstract] [Full Text] [Related]

  • 14. A sinusoidal large cell lymphoma with expression of CD30, CD15, and multiple B-cell antigens: a classical Hodgkin lymphoma with sinusoidal infiltrating pattern or a sinusoidal CD30 positive large B-cell lymphoma with CD15?
    Wang E, Foo WC, Huang Q.
    Leuk Lymphoma; 2010 Jun 04; 51(6):1148-51. PubMed ID: 20443679
    [No Abstract] [Full Text] [Related]

  • 15. Peripheral T-cell lymphomas expressing CD30 and CD15.
    Barry TS, Jaffe ES, Sorbara L, Raffeld M, Pittaluga S.
    Am J Surg Pathol; 2003 Dec 04; 27(12):1513-22. PubMed ID: 14657710
    [Abstract] [Full Text] [Related]

  • 16. Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.
    Mohri T, Ikura Y, Hirakoso A, Okamoto M, Hishizawa M, Takaori-Kondo A, Kato S, Nakamura S, Yoshimura K, Okabe H, Iwai Y.
    Int J Hematol; 2018 Aug 04; 108(2):218-227. PubMed ID: 29380181
    [Abstract] [Full Text] [Related]

  • 17. PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.
    Arun I, Roy P, Arora N, Bhave SJ, Nair R, Chandy M.
    Int J Surg Pathol; 2017 Jun 04; 25(4):333-338. PubMed ID: 28013563
    [Abstract] [Full Text] [Related]

  • 18. Cytomorphologic differentiation of Hodgkin's lymphoma and Ki-1+ anaplastic large cell lymphoma in fine needle aspirates.
    Mourad WA, al Nazer M, Tulbah A.
    Acta Cytol; 2003 Jun 04; 47(5):744-8. PubMed ID: 14526672
    [Abstract] [Full Text] [Related]

  • 19. JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology.
    Fitzpatrick MJ, Massoth LR, Marcus C, Vergilio JA, Severson E, Duncan D, Ramkissoon SH, Hasserjian RP, Kim AS, Sohani AR, Williams EA, Nardi V.
    Am J Surg Pathol; 2021 Jul 01; 45(7):895-904. PubMed ID: 34105517
    [Abstract] [Full Text] [Related]

  • 20. [Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma].
    Zhou X, Zhao T, Qi Z, Liu G, Zhu M.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1532-5. PubMed ID: 12609061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.